Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 15.31M | $4.0M | 1.91% | -- | 2026-06-30 |
| 683 Capital Management, LLC | 11.78M | $3.0M | 1.47% | -222.1K | 2026-06-30 |
| BANK OF AMERICA CORP /DE/ | 8.20M | $2.0M | 1.02% | -6 | 2026-06-30 |
| Defilade Capital Management, L.P. | 7.56M | $2.0M | 0.94% | -- | 2026-06-30 |
| Newtyn Management, LLC | 3.00M | -- | 0.37% | -4.08M | 2026-06-30 |
| Tejara Capital Ltd | 2.04M | -- | 0.25% | -- | 2026-06-30 |
| UBS Group AG | 1.45M | -- | 0.18% | -42.5K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 1.32M | -- | 0.16% | -- | 2026-06-30 |
| CITADEL ADVISORS LLC | 1.00M | -- | 0.12% | +545.3K | 2026-06-30 |
| EcoR1 Capital, LLC | 1.00M | -- | 0.12% | -12.37M | 2026-06-30 |
